As a leading expert in biopharmaceutical research and development, Ivan Kairatov has spent his career at the forefront of medical innovation. Today, he joins us to discuss a significant breakthrough in the fight against the Epstein-Barr virus—a pathogen that infects an estimated 95% of the world's
In the high-stakes world of pharmaceutical development, a successful Phase 3 trial is typically a cause for celebration, yet Ocular Therapeutix's recent announcement for its wet AMD treatment, Axpaxli, was met with a starkly different reality. The drug achieved its primary endpoint with statistical
A recent comprehensive analysis of nearly 15,000 Medicare users has significantly reshaped the understanding of virtual care, revealing its indispensable role in managing a vast array of physical health conditions. Contrary to the widespread belief that telehealth primarily serves mental and
The aftermath of a spinal cord injury unleashes a devastating and prolonged biological assault, where the secondary damage cascade often proves more destructive than the initial physical trauma. This secondary injury process is a complex storm of excessive reactive oxygen species, relentless
In the complex world of health and longevity, the simple advice to "eat better" often feels vague. To bring clarity to this crucial topic, we sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development provides a unique lens on the interplay between diet,
The seamless integration of advanced robotics with the human body represents a monumental leap in medical technology, yet the success of these innovations hinges on a factor far more subtle than mere mechanical efficiency. As AI-powered prosthetic limbs evolve to include semi-autonomous functions
A groundbreaking study published in the journal Genes has fundamentally altered the scientific landscape for hypermobile Ehlers-Danlos syndrome (hEDS), proposing that the condition’s origins are not rooted in a single genetic flaw but rather a complex accumulation of variants across three distinct
The paradigm of healthcare delivery is undergoing a fundamental and rapid transformation, moving away from traditional in-person visits toward a more accessible, data-driven, and remote model. This evolution is not merely a consequence of recent global events but the culmination of technological
The single greatest risk factor for developing Parkinson's disease has been systematically overlooked in the very laboratories dedicated to finding a cure, a baffling disconnect that a global consortium of scientists is now moving urgently to correct. For decades, the relentless march toward
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
